US Medical Autoimmune Diabetes Medical Director
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Sanofi has recently embarked into a vast and ambitious digital transformation program. A cornerstone of this roadmap is the acceleration of its data transformation and of the adoption of artificial intelligence (AI) and machine learning (ML) solutions, to accelerate R&D, manufacturing and commercial performance and bring better drugs and vaccines to patients faster, to improve health and save lives.
In General Medicines, we are dedicated to improving health for the millions of individuals we serve, but too many people are still not receiving the care they need. We want to expand our reach and elevate the standard of care in chronic conditions, by continuously evolving to stay relevant to customers. And each of us living the Play to Win behaviors.
Building on our mission to deliver best- and first-in-class medicines we recently acquired Provention Bio. By coupling Provention Bio’s transformative innovation with Sanofi’s expertise, we aim to bring life-changing benefits to people at risk of developing autoimmune type 1 diabetes (aT1D). TZIELD (Teplizumab), a CD3-directed antibody is the first and only treatment indicated to delay onset of Stage 3 T1D.
Map, evaluate and identify gaps and barriers at the national/regional/local for implementation of screening programs (completed, on-going, planned) in clinical practice across the US, including various methods involved in aT1D risk identification (i.e., genetic and autoantibody screening)
Working with cross-functional colleagues (US and Global), develop a clear strategy and drive innovative solutions with stakeholders (internal and external to include commercial/research labs and organizations) to close identified gaps/barriers through education, research and other means of support, ensuring adequate diagnostic tools are available, accessible and accurate to support testing needs in the short term and fully embedded in the long-term strategy.
Develop and execute a mid- and long-term strategy to provide the evidence and rationale for supporting a cost-effective transition from first-degree relatives to population-based screening by the United States Preventive Services Task Force (USPSTF) and the American Academy of Pediatrics (AAP)
Identify and collaborate to establish comprehensive medical education/scientific content creations around assessing the risk of clinical type 1 diabetes, screening for type 1 diabetes with autoantibody testing and metabolic monitoring those with positive antibodies.
Develop partnerships and collaborative relationships with emerging or established programs for genetic screening for aT1D to include state newborn screening and consumer companies (eg. 23&me)
Identify comprehensive educational outcomes/metrics to measure and identify ongoing gaps in advancing screening.
Collaborate with KOLs and scientific societies/organisations critical in screening activities and participate in evolution of screening guidelines and consensus statements.
Drive strategic partnerships with KOL/DOL/societies related to screening.
Develop HCP peer-to-peer communities in the US around aT1D screening in collaboration with the omnichannel lead.
Work with scientific societies and scientific/clinical experts to develop tools for screening to more accurately predict progression of early-stage aT1D
Key Qualifications and Competencies:
Doctoral degree preferred (MD/DO, PhD or PharmD)
Experience/training in autoimmune type 1 diabetes preferred
Good understanding of the early aT1D screening landscape
Prior experience in autoimmune type 1 diabetes screening activities is desired.
Ability to understand and effectively communicate scientific and medical data results and information to internal and external stakeholders
Prior experience in a US matrix environment.
Ability to work cross-functionally, with strong global approach, agile and strong team player.
Desired traits & PTW behaviors
Rigor, attention to details
Strong interpersonal skills with the ability to collaborate with others
A team player; able to collaborate successfully with both internal and external colleagues
Excellent communication skills both written and oral English
Committed to ethics and scientific standards
Strong analytical skills, comfort managing through ambiguity
Understanding and success in dealing with different cultures and diversity
Ability to manage competing priorities and projects, requiring an excellent ability to prioritize and manage expectations.
A spirit to consistently seek opportunities to learn and develop
An absolute commitment to ethical standards and compliance
Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.
At Sanofi diversity and inclusion is foundational to how we operate and embedded in our Core Values. We recognize to truly tap into the richness diversity brings we must lead with inclusion and have a workplace where those differences can thrive and be leveraged to empower the lives of our colleagues, patients and customers. We respect and celebrate the diversity of our people, their backgrounds and experiences and provide equal opportunity for all.